BioNTech SE(DE:22UA)
€78.65+1.00 (+1.29%)
DE:22UA
BioNTech SE Revenue
€78.65
At close:+1.00 (+1.29%)
BioNTech SE (22UA) Revenue
63 Followers
BioNTech SE Revenue
BioNTech SE had a revenue of 1.29B in the quarter ending Sep 30, 2026, with 1120.83%. This bring the company's revenue in the last twelve months to 2.41B, Decreased 8.69%. In the fiscal year ending Dec 31, 2025, BioNTech SE had annual revenue of 2.76B with 0.20% growth.
- Revenue (ttm)
- 2.41B
- Revenue Growth
- -23.23%
- P/S Ratio
- 7.07
- Revenue/Employee
- EUR 353,098
- Employees
- 7,807
- Market Cap
- EUR 19.49B
Revenue Chart
BioNTech SE Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.76B | 5.53M | 0.20% |
| Dec 31, 2024 | 2.75B | -1.07B | -27.96% |
| Dec 31, 2023 | 3.82B | -13.49B | -77.94% |
| Dec 31, 2022 | 17.31B | -1.67B | -8.78% |
| Dec 31, 2021 | 18.98B | 18.49B | 3834.63% |
| Dec 31, 2020 | 482.30M | 373.70M | 344.11% |
| Mar 31, 2020 | 108.60M | -18.98M | -14.87% |
| Dec 31, 2018 | 127.58M | 65.98M | 107.11% |
| Dec 31, 2017 | 61.60M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.